Cargando…

Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold

BACKGROUND: A recently published Ugandan study on tuberculosis (TB) diagnosis in HIV-positive patients with presumptive smear-negative TB, which showed that out of 90 patients who started TB treatment, 20% (18/90) had a positive Xpert MTB/RIF (Xpert) test, 24% (22/90) had a negative Xpert test, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Decroo, Tom, Henríquez-Trujillo, Aquiles R., De Weggheleire, Anja, Lynen, Lutgarde
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5637087/ https://www.ncbi.nlm.nih.gov/pubmed/29020943 http://dx.doi.org/10.1186/s12879-017-2798-6

Ejemplares similares

The therapeutic threshold in clinical decision-making for TB
por: de Rooij, Madeleine L, et al.
Publicado: (2023)

An observational report of universal GeneXpert testing of inpatients with diagnosed or presumptive TB in the Philippines
por: Thi, Aye Myat, et al.
Publicado: (2020)

Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation
por: Raizada, Neeraj, et al.
Publicado: (2018)

Chest Radiography and Xpert MTB/RIF® Testing in Persons with Presumptive Pulmonary TB: Gaps and Challenges from a District in Karnataka, India
por: Kanakaraju, Manjula, et al.
Publicado: (2020)

Enhancing TB Case Detection: Experience in Offering Upfront Xpert MTB/RIF Testing to Pediatric Presumptive TB and DR TB Cases for Early Rapid Diagnosis of Drug Sensitive and Drug Resistant TB
por: Raizada, Neeraj, et al.
Publicado: (2014)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Presumptive tests.
por: Flamm, W G
Publicado: (1978)

Case Report: Therapeutic Threshold for Rifampicin-Resistant Tuberculosis in a Patient from Maputo, Mozambique
por: Gonzaga, Lorena D. M., et al.
Publicado: (2021)

Treatment decisions and mortality in HIV-positive presumptive smear-negative TB in the Xpert® MTB/RIF era: a cohort study
por: Hermans, Sabine M., et al.
Publicado: (2017)

Diagnosis of tuberculosis from smear-negative presumptive TB cases using Xpert MTB/Rif assay: a cross-sectional study from Nepal
por: Khadka, Priyatam, et al.
Publicado: (2019)

Development of a risk score to guide targeted hepatitis C testing among human immunodeficiency virus patients in Cambodia
por: De Weggheleire, Anja, et al.
Publicado: (2021)

Clinical Impact and Cost-effectiveness of Xpert MTB/RIF Testing in Hospitalized Patients With Presumptive Pulmonary Tuberculosis in the United States
por: Cowan, James F., et al.
Publicado: (2017)

Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
por: Ndlovu, Zibusiso, et al.
Publicado: (2018)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Cost and operational impact of promoting upfront GeneXpert MTB/RIF test referrals for presumptive pediatric tuberculosis patients in India
por: Sarin, Sanjay, et al.
Publicado: (2019)

The Efficiency of TB LAM Antigen Test to Xpert MTB/RIF Ultra Test for the Diagnosis of Tuberculous Pericarditis Using Pericardial Fluid Samples
por: Alomatu, Samuel, et al.
Publicado: (2023)

Impact of introduction of Xpert MTB/RIF test on tuberculosis (TB) diagnosis in a city with high TB incidence in Brazil
por: Pereira, Giovana Rodrigues, et al.
Publicado: (2018)

False Rifampicin Resistance in Xpert Ultra Applied to Lymph Node Aspirate: A Case Report
por: Ng, Kamela C S, et al.
Publicado: (2020)

The Sensitivity and Specificity of Using a Computer Aided Diagnosis Program for Automatically Scoring Chest X-Rays of Presumptive TB Patients Compared with Xpert MTB/RIF in Lusaka Zambia
por: Muyoyeta, Monde, et al.
Publicado: (2014)

Diagnostic accuracy of Xpert MTB/RIF Ultra and culture assays to detect Mycobacterium Tuberculosis using OMNIgene-sputum processed stool among adult TB presumptive patients in Uganda
por: Sessolo, Abdulwahab, et al.
Publicado: (2023)

Temporary disengagement and re-engagement in human immunodeficiency virus care in a rural county serving pastoralist communities in Kenya: a retrospective cohort study
por: Yonga, Paul, et al.
Publicado: (2019)

Implementation of GeneXpert for TB Testing in Low- and Middle-Income Countries: A Systematic Review
por: Brown, Scott, et al.
Publicado: (2021)

Accuracy of GenoQuick MTB test in detection of Mycobacterium tuberculosis in sputum from TB presumptive patients in Uganda
por: Kaswabuli, Sylvia, et al.
Publicado: (2022)

Comparison of predictive models for hepatitis C co-infection among HIV patients in Cambodia
por: Buyze, Jozefien, et al.
Publicado: (2020)

Use of Xpert Contributes to Accurate Diagnosis, Timely Initiation, and Rational Use of Anti-TB Treatment Among Childhood Tuberculosis Cases in South Central Ethiopia
por: Sorsa, Abebe, et al.
Publicado: (2020)

The value of lateral flow urine lipoarabinomannan assay and empirical treatment in Xpert MTB/RIF ultra negative patients with presumptive TB: a prospective cohort study
por: Kebede, Wakjira, et al.
Publicado: (2021)

Piloting Upfront Xpert MTB/RIF Testing on Various Specimens under Programmatic Conditions for Diagnosis of TB & DR-TB in Paediatric Population
por: Raizada, Neeraj, et al.
Publicado: (2015)

Clinician Testing and Treatment Thresholds for Management of Urinary Tract Infection
por: Harris, Andrea, et al.
Publicado: (2023)

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

1319. Events of Disengagement from HIV care and Subsequent Reengagement in a Kenyan Pastoralist Community: Frequency, Determinants, and Patient Views
por: Yonga, Paul Otieno, et al.
Publicado: (2019)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Virological outcomes and risk factors for non-suppression for routine and repeat viral load testing after enhanced adherence counselling during viral load testing scale-up in Zimbabwe: analytic cross-sectional study using laboratory data from 2014 to 2018
por: Mhlanga, Trudy Tholakele, et al.
Publicado: (2022)

Outcomes of a clinical diagnostic algorithm for management of ambulatory smear and Xpert MTB/Rif negative HIV infected patients with presumptive pulmonary TB in Uganda: a prospective study
por: Walusimbi, Simon, et al.
Publicado: (2016)

Better programmatic outcome with the shorter regimen for the treatment of multidrug-resistant tuberculosis (MDR-TB) in Guinea: A retrospective cohort study
por: Hassane-Harouna, Souleymane, et al.
Publicado: (2020)

Diagnostic Performance of Xpert MTB/RIF Ultra Compared with Predecessor Test, Xpert MTB/RIF, in a Low TB Incidence Setting: a Retrospective Service Evaluation
por: Mansfield, Mary, et al.
Publicado: (2022)

Correction to: Clinician Testing and Treatment Thresholds for Management of Urinary Tract Infection
Publicado: (2023)

Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2019)

Catching the Missing Million: Experiences in Enhancing TB & DR-TB Detection by Providing Upfront Xpert MTB/RIF Testing for People Living with HIV in India
por: Raizada, Neeraj, et al.
Publicado: (2015)

Diagnostic Performance of the Fujifilm SILVAMP TB-LAM in Children with Presumptive Tuberculosis
por: Comella-del-Barrio, Patricia, et al.
Publicado: (2021)

GeneXpert for TB diagnosis: planned and purposeful implementation
por: Piatek, Amy S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4nsgo17gqaqej01lon1ajsnf9n